Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00577512 · OUTCOME

Number of Subjects Treated With (HD DTPACE Obtain a Complete Response or Near Complete Response That Lasts for 6 Months or Longer.

2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE · Source last updated 2017-11-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participant response
Interval / dispersion
Not reported
Time frame
12 months

What was measured

Complete Response (CR) defined as all of the following for a minimum of 2 months: a) absence of urine and serum M-components by immunofixation; b) bone marrow should be adequately cellular (\>20%); c) normal serum calcium; d) no new bone lesions or enlargement of existing lesions. Near Complete Response included all elements of CR except immunofixation studies remained positive.

Groups in this outcome

HD DTPACE

1. High dose DTPACE and stem cell collection if you do not already have sufficient stem cells stored 2. High dose DTPACE and stem cell re-infusion 3. VTD Maintenance therapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
HD DTPACE4

Reported measurements

Source class 1
Values in participant response · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
HD DTPACE0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      4
    units
    Participants
description
Complete Response (CR) defined as all of the following for a minimum of 2 months: a) absence of urine and serum M-components by immunofixation; b) bone marrow should be adequately cellular (\>20%); c) normal serum calcium; d) no new bone lesions or enlargement of existing lesions. Near Complete Response included all elements of CR except immunofixation studies remained positive.
groups
  1. description
    1. High dose DTPACE and stem cell collection if you do not already have sufficient stem cells stored 2. High dose DTPACE and stem cell re-infusion 3. VTD Maintenance therapy
    id
    OG000
    title
    HD DTPACE
param Type
NUMBER
reporting Status
POSTED
time Frame
12 months
title
Number of Subjects Treated With (HD DTPACE Obtain a Complete Response or Near Complete Response That Lasts for 6 Months or Longer.
type
PRIMARY
unit Of Measure
participant response

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice